SCHEMBL4308213

SCHEMBL4308213

OC(O)C1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1132940 1.00
Hydrochloric Acid SCHEMBL27857854 0.97
SCHEMBL3970325 0.92
SCHEMBL20334775 0.92
SCHEMBL3469054 0.90 HIF1A (0.46)
SCHEMBL2500151 0.79
SCHEMBL447351 0.79
SCHEMBL21022704 0.79
SCHEMBL21090095 0.79 HIF1A (0.38)
SCHEMBL18735919 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0938286-B1 REDUCTION OF HAIR GROWTH GILLETTE CO (US) 2003-11-05 EP claimed
EP-4112631-A1 CASPASE-2 INHIBITOR COMPOUNDS Kintsugi Therapeutics S.L. (ES) 2023-01-04 EP disclosed
EP-3885337-A1 FTO INHIBITORS National Institute Of Biological Sciences, Beijing (CN) 2021-09-29 EP disclosed
WO-2020228478-A1 ANTI-TUMOR DIAZOBICYCLIC APOPTOSIS PROTEIN INHIBITOR 南京华威医药科技集团有限公司 2020-11-19 WO disclosed
US-10441571-B2 Spiro-lactam NMDA receptor modulators and uses thereof APTINYX INC. (US) 2019-10-15 US disclosed
EP-3305900-A1 ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES Nuevolution A/S (DK) 2018-04-11 EP disclosed
WO-2012166665-A2 BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS, INC. (US) 2012-12-06 WO disclosed
EP-2084519-A2 ADVANCED DRUG DEVELOPMENT AND MANUFACTURING Los Alamos National Security, LLC (US) 2009-08-05 EP disclosed
WO-2008127291-A2 ADVANCED DRUG DEVELOPMENT AND MANUFACTURING LOS ALAMOS NATIONAL SECURITY, LLC (US) 2008-10-23 WO disclosed
WO-2008002039-A1 QUINAZOLINE DERIVATIVES FOR INHIBITING THE GROWTH OF CANCER CELL HANMI PHARM. CO., LTD. (KR) 2008-01-03 WO disclosed
EP-1181274-A4 IMINOCYCLITOL INHIBITORS OF HEXOAMINIDASE AND GLYCOSIDASE SCRIPPS RESEARCH INST (US) 2005-08-17 EP disclosed
EP-0938286-B1 REDUCTION OF HAIR GROWTH GILLETTE CO (US) 2003-11-05 EP disclosed
EP-1181274-A1 IMINOCYCLITOL INHIBITORS OF HEXOAMINIDASE AND GLYCOSIDASE The Scripps Research Institute (US) 2002-02-27 EP disclosed
WO-2000068194-A1 IMINOCYCLITOL INHIBITORS OF HEXOAMINIDASE AND GLYCOSIDASE THE SCRIPPS RESEARCH INSTITUTE (US) 2000-11-16 WO disclosed
EP-0938286-A1 REDUCTION OF HAIR GROWTH HANDELMAN, Joseph H. (US) 1999-09-01 EP disclosed
US-5908867-A Reduction of hair growth HENRY JAMES P (US) 1999-06-01 US disclosed
WO-1998003149-A1 REDUCTION OF HAIR GROWTH HANDELMAN, JOSEPH, H. (US) 1998-01-29 WO disclosed